Faculty profile

Dominic Raco

Back to faculty

Assistant Clinical Professor (Adjunct)MedicineMcMaster University

Dominic Raco

Assistant Clinical Professor (Adjunct)

Medicine

Faculty of Health Sciences

McMaster University

Hamilton, Ontario, Canada

In this role since 2025

Supervision signals

Adjunct, part-time and visiting faculty usually co-supervise alongside a core faculty member.
No graduate courses on record.
6 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.

These signals come from public records. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

5,915

Citations

h-index

Collaborators

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Academic profiles

University Profile Search on Google Scholar OpenAlex

Social profiles

𝕏Search on X inSearch on LinkedIn 🦋Search on Bluesky ▶Search on YouTube

Contact

racod@mcmaster.ca

Research

Research areas, by share of publications

Acute Myocardial Infarction ResearchMedicine
Antiplatelet Therapy and Cardiovascular DiseasesMedicine
Coronary Interventions and DiagnosticsMedicine
Atrial Fibrillation Management and OutcomesMedicine

Research areas are derived from OpenAlex topics of their publications.

33 publications.

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

Raco M, Raco D

ACP journal club2026Senior author

DOI: 10.7326/annals-26-02439-jc

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

Raco M, Raco D

ACP journal club2026Senior author

DOI: 10.7326/annals-26-02438-jc

In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.

Raco MD, Raco DL

ACP journal club2025Senior author

DOI: 10.7326/annals-24-03735-jc

In type 2 MI, the T2-risk score predicted death or MI at 1 y.

Raco DL

ACP journal club20231 citationsFirst author

DOI: 10.7326/j23-0027

In type 2 MI, the T2-risk score predicted death or MI at 1 y (vol 176, pg JC58, 2023)

Raco DL

Annals of Internal Medicine2023First author

In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF hospitalization.

Raco DL

ACP journal club2022First author

DOI: 10.7326/j22-0100

In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.

Raco DL

ACP journal club2020First author

DOI: 10.7326/acpj202001210-004 PMID: W2999257952

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

Raco DL

ACP journal club2020First author

DOI: 10.7326/acpj202001210-005 PMID: W3000497502

PROTAMINE REVERSAL POST HEPARIN ADMINISTRATION FOR IMMEDIATE FEMORAL SHEATH REMOVAL IN CORONARY CATHETERIZATION/INTERVENTION: VASCULAR AND CARDIAC SAFETY AND EFFICACY

Lin J, Gaidhu N, Awan R, Kong W, Amlani S, Raco D, Hussain F

Canadian Journal of Cardiology20181 citations

DOI: 10.1016/j.cjca.2018.07.442

After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy.

Raco DL

ACP journal club2017First author

DOI: 10.7326/acpjc-2017-167-12-070

Researchers with similar interests

Shamir Mehta

Medicine

Acute Myocardial Infarction Research, Antiplatelet Therapy and Cardiovascular Diseases

Michael Tsang

Medicine

Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics

Sanjit Jolly

Medicine

Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics

Madhu Natarajan

Medicine

Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics

Nikita Malhotra

Medicine

Antiplatelet Therapy and Cardiovascular Diseases, Coronary Interventions and Diagnostics

Anthony Wassef

Medicine

Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student: Acute Myocardial Infarction Research Dear Professor Raco, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Open in email

Something wrong or missing on this profile? Suggest a correction

Dominic Raco

Research

In AF at risk for stroke and bleeding, LAAC was not noninferior to medical therapy for a composite of thromboembolic and safety events.

In AF, LAAC was noninferior to NOAC therapy for a composite efficacy outcome and reduced non-procedure-related bleeding at 3 y.

In asymptomatic severe AS, early TAVR vs. clinical surveillance reduced a composite of death, stroke, or CV hospitalization.

In type 2 MI, the T2-risk score predicted death or MI at 1 y.

In type 2 MI, the T2-risk score predicted death or MI at 1 y (vol 176, pg JC58, 2023)

In ischemic left ventricular systolic dysfunction, adding PCI to medical therapy did not reduce death or HF hospitalization.

In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding.

In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y.

PROTAMINE REVERSAL POST HEPARIN ADMINISTRATION FOR IMMEDIATE FEMORAL SHEATH REMOVAL IN CORONARY CATHETERIZATION/INTERVENTION: VASCULAR AND CARDIAC SAFETY AND EFFICACY

After PCI in AF, dual antithrombotic therapy with dabigatran reduced bleeding compared with triple therapy.

Frequent collaborators

James Velianou

Salim Yusuf

Koon Teo

Amritanshu Pandey

Akbar Panju

Madhu Natarajan

Researchers with similar interests

Shamir Mehta

Michael Tsang

Sanjit Jolly

Madhu Natarajan

Nikita Malhotra

Anthony Wassef